Studies by electron microscopy on the assembly of duck hepatitis B virus in the liver

Liver specimens from 1-day-old ducklings infected in ovo with maternally transmitted duck hepatitis B virus (DHBV) were examined by electron microscopy. Complete and incomplete DHBV particles were located within hypertrophied cisternae of the endoplasmic reticulum of the hepatocytes. The complete viral particles found intracellularly have inner cores with a diameter ranging from 35 to 37.5 nm and an outer coat or envelope. The whole particle measures approximately 45-65 nm in diameter. Naked core particles were located in the nuclei, free in the cytoplasm, and also near or on the cisternal membrane of the endoplasmic reticulum on the cytoplasmic face. Duck hepatitis B virions appear to share morphological characteristics with the viral coat and core of human hepatitis B virus (HBV). Electron microscopy suggested that the core particles of DHBV migrate from the nucleus into the cytoplasm through the nuclear pores. The complete viral particles are probably formed by protrusion of the core particles through the endoplasmic reticulum and by simultaneous encapsulation with a coat derived from the endoplasmic reticulum.     

新型介孔二氧化硅纳米微球/羟基磷灰石/生物玻璃复合生物涂层的体外理化特性

目的本实验设计制备了介孔硅纳米微球(mesoporous silica nanoparticulate,MSN)/羟基磷灰石(hydroxyapatite,HA)/生物玻璃(bioactive glass,BG)复合生物涂层。并对其加载唑来膦酸(Zoledronic acid,ZOL)后的体外药物释放特性进行了研究。方法通过扫描电镜、透射电镜及能谱仪等方法观察H/M涂层表征。通过高效液相色谱法进行HA/MSN/BG、HA/MSN及HA生物涂层体外ZOL加载及释放的比较。结果通过扫描电镜观察HA/MSN涂层,发现其具有二氧化硅微球组成的多孔结构。体外药物实验中H/M比HA载药量大更且与初始药物浓度相关,并具有药物缓释的特性,涂布BG后缓释效应更加明显。结论 H/M/B因其具有载药量大及药物缓释特性,为生物涂层内固定物在骨折愈合上的应用提供了新技术。     

Cellular automata model for drug release from binary matrix and reservoir polymeric devices

Kinetics of drug release from polymeric tablets, inserts and implants is an important and widely studied area. Here we present a new and widely applicable cellular automata model for diffusion and erosion processes occurring during drug release from polymeric drug release devices. The model divides a 2D representation of the release device into an array of cells. Each cell contains information about the material, drug, polymer or solvent that the domain contains. Cells are then allowed to rearrange according to statistical rules designed to match realistic drug release. Diffusion is modeled by a random walk of mobile cells and kinetics of chemical or physical processes by probabilities of conversion from one state to another. This is according to the basis of diffusion coefficients and kinetic rate constants, which are on fundamental level just probabilities for certain occurrences. The model is applied to three kinds of devices with different release mechanisms: erodable matrices, diffusion through channels or pores and membrane controlled release. The dissolution curves obtained are compared to analytical models from literature and the validity of the model is considered. The model is shown to be compatible with all three release devices, highlighting easy adaptability of the model to virtually any release system and geometry. Further extension and applications of the model are envisioned.     

Engineering multi-stage nanovectors for controlled degradation and tunable release kinetics

Nanovectors hold substantial promise in abating the off-target effects of therapeutics by providing a means to selectively accumulate payloads at the target lesion, resulting in an increase in the therapeutic index. A sophisticated understanding of the factors that govern the degradation and release dynamics of these nanovectors is imperative to achieve these ambitious goals. In this work, we elucidate the relationship that exists between variations in pore size and the impact on the degradation, loading, and release of multistage nanovectors. Larger pored vectors displayed faster degradation and higher loading of nanoparticles, while exhibiting the slowest release rate. The degradation of these particles was characterized to occur in a multi-step progression where they initially decreased in size leaving the porous core isolated, while the pores gradually increased in size. Empirical loading and release studies of nanoparticles along with diffusion modeling revealed that this prolonged release was modulated by the penetration within the porous core of the vectors regulated by their pore size.     

Modelling of sustained release of water-soluble drugs from porous,hydrophobic polymers

The release behaviour of water-soluble drugs from hydrophobic, porous polymeric matrices is complicated by the dissolution of the drug in the water-filled pores under quiescent conditions. Mathematical models are presented for drug release above and below the solubility limit of the drug in the dissolution medium, for constant void fraction (porosity). Experimental studies of KCI release from porous ethyl cellulose tablets in water at 37°C are explained in terms of dissolution-controlled and diffusion-controlled steps of the release mechanism.     

Nonspecific esterase released from thymic macrophages accumulates in the apoptotic thymocytes: an indication for this enzyme participating in the clearance of apoptotic thymocytes

In the mouse thymus, a large number of developing thymocytes die through apoptosis each day. It has been proposed that thymic macrophages are responsible for clearance of the massive number of thymocytes that die through apoptosis. The detailed clearance mechanism by which macrophages remove the apoptotic cells is not clear. Our in vitro studies in this report show that nonspecific esterase (NSE), a cytochemical marker enzyme of macrophages, was secreted from thymic macrophages as a consequence of stimulation by interaction with thymocytes, and the esterase accumulated in these macrophage-binding thymocytes (MBT). TUNEL staining demonstrated that these MBT were undergoing apoptosis. The inability to exclude eosin Y and the presence of pores on the plasma membrane were further evidence for the disintegration of these MBT. In vivo, the release of NSE was evident by the presence of NSE activity in the extracellular space between the macrophages and apoptotic thymocytes under the transmission electron microscope after dexamethasone injection, which causes massive apoptosis of thymocytes. Inhibition study showed that the inhibition of NSE delayed the MBT progressing to the late apoptotic phase. These results suggest that the NSE released from macrophages is involved in the clearance of apoptotic thymocytes.     

Influence of betacyclodextrin on the release of poorly soluble drugs from inert and hydrophilic heterogeneous polymeric matrices

The release behavior of poorly soluble drugs (naproxen and ketoprofen) from inert (acrylic resins) and hydrophilic swellable (high-viscosity hydroxypropylmethylcellulose) tableted matrices containing betacyclodextrin (betaCD) was investigated. The results demonstrated that, in both cases, betaCD can enhance the rate of drug release. Matrices obtained from formulations in which lactose replaced betaCD were also evaluated. BetaCD in inert matrices causes a dramatic increase in the rate of drug release, higher than that promoted by lactose which merely acts as a channelling agent. This result suggests that possible in situ formation of the drug-betaCD complex. which causes an improvement in apparent drug solubility, could have a greater influence on the rate of drug release than the possible increase of water uptake by a soluble filler. Indeed, if the opposite were true, lactose would be more effective in increasing the rate of drug release than betaCD, because of its greater solubility in water. On the contrary, in the case of hydrophilic matrices, lactose proves to be much more effective in promoting drug release than betaCD. It seems that, while the bulky interaction compound can freely diffuse through water-filled pores of inert systems, its diffusion through swollen macromolecular chains of hydrophilic matrices may be hindered. This hypothesis was supported by data obtained from binary (drug/polymer) and ternary (drug/polymer/betaCD) hydrophilic matrices using a betaCD-containing dissolution media.     

Sol-gel processed porous silica carriers for the controlled release of diclofenac diethylamine

Silica xerogels doped with diclofenac diethylamine were prepared by the sol-gel method from a hydrolysed tetraethoxysilane (TEOS) solution containing diclofenac diethylamine. Two different catalysts, drying conditions and levels of water content were used to alter the microstructure of the silica xerogels. The aim of this study was to determine the rate of Diclofenac release from the silica xerogels. This in vitro study showed that the sol-gel method is useful for entrapping Diclofenac in the pores of xerogels. It also showed that, in vitro, Diclofenac is released from the silica xerogel, through the pores, by diffusion. Base-catalysed gels proved to be much more effective than acid-catalyzed gels.     

Coat protein of potyviruses 7. Amino acid sequence of peanut stripe virus

Summary The amino acid sequence of the 287-residue coat protein of peanut stripe virus (PStV) was determined from the sequences of overlapping peptide fragments. Results indicated that the amino terminus was blocked by an acetyl group, as has previously been found for the coat protein of Johnsongrass mosaic potyvirus. Comparison of the PStV sequence with coat proteins of 20 distinct potyviruses gave sequence identities of 47–57%, except for zucchini yellow mosaic virus (ZYMV), passionfruit woodiness virus (PWV), and the related strains watermelon mosaic virus 2 (WMV 2) and soybean mosaic virus-N, which showed sequence identities of 70–76%. Several amino acid residues which were common to the core sequences of these coat proteins were at positions previously found to be invariant among potyvirus coat proteins. The degree of these similarities suggests that although PStV, WMV 2, ZYMV, and PWV are distinct potyviruses, they share a common ancestor in their evolutionary development.     

Limited proteolysis of alfalfa mosaic virus: influence on the structural and biological function of the coat protein

Limited tryptic digestion of intact alfalfa mosaic virus resulted in the quantitative removal of 27 amino acids from the N-terminal portions of the coat protein subunits. The release of this peptide material, which contains a relatively high number of basic residues, causes a breakdown of the bacilliform viral components into spherical nucleoprotein particles. From this it was concluded that the proteolytic cleavage interferes with protein-RNA interactions in the virus, but not with protein-protein interactions. The release of the N-terminal peptide also destroyed the capacity of the coat protein to activate the alfalfa mosaic virus genome. This supports the hypothesis that this activation is accomplished by a specific interaction of the coat protein with alfalfa mosaic virus RNAs.     

Formulation and characterization of modified release tablets containing isoniazid using swellable polymers

The aim of this work was to develop swellable modified release (MR) isoniazid tablets using different combinations of polyvinyl acetate (PVAc) and sodium-carboxymethylcellulose (Na-CMC). Granules were prepared by moist granulation technique and then compressed into tablets. In vitro release studies for 12 hr were carried out in dissolution media of varying pH i.e. pH 1.2, 4.5, 7.0 and 7.5. Tablets of all formulations were found to be of good physical quality with respect to appearance (width and thickness), content uniformity, hardness, weight variation and friability. In vitro release data showed that increasing total polymer content resulted in more retarding effect. Formulation with 35% polymer content exhibited zero order release profile and it released 35% of the drug in first hr, later on, controlled drug release was observed upto the 12(th) hour. Formulations with PVAc to Na-CMC ratio 20:80 exhibited zero order release pattern at levels of studied concentrations, which suggested that this combination can be used to formulate zero order release tablets of water soluble drugs like isoniazid. Korsmeyer-Peppas modeling of drug release showed that non-Fickian transport is the primary mechanism of isoniazid release from PVAc and Na-CMC based tablets. The value of mean dissolution time decreased with the increase in the release rate of drug clearly showing the retarding behavior of the swellable polymers. The application of a mixture of PVAc to Na-CMC in a specific ratio may be feasible to formulate zero order release tablets of water soluble drugs like isoniazid.     

Determination of pore diameter and molecular weight cut-off of hydrogel-membrane liquid-core capsules for immunoisolation.

The exclusion limit expressed as the largest pore size of capsules composed of hydrogel Ca-alginate membrane and hydroxy-propyl-ammonium starch liquid core considered as the immunoprotective system has been determined by means of inverse size exclusion chromatography with dextran molecular weight standards. The exclusion limits of the capsules were not influenced by the change of starch concentration in the core solution from 4 to 6% but were influenced by the change in alginate concentration in the membrane from 0.5 to 1.0%, causing the membranes to be less permeable. It was found that the diameter of the largest pores in hydrogel membranes was in the range 7.2-8.0 nm. Based on the relationship between solute size and its molecular weight, the capsules had an approximate exclusion limit of 21-25 kD for dextran and 78-103 kD for protein, which is sufficient to block the antibodies penetrating through the membrane.     

Determination of pore diameter and molecular weight cut-off of hydrogel-membrane liquid-core capsules for immunoisolation

The exclusion limit expressed as the largest pore size of capsules composed of hydrogel Ca-alginate membrane and hydroxy-propyl-ammonium starch liquid core considered as the immunoprotective system has been determined by means of inverse size exclusion chromatography with dextran molecular weight standards. The exclusion limits of the capsules were not influenced by the change of starch concentration in the core solution from 4 to 6% but were influenced by the change in alginate concentration in the membrane from 0.5 to 1.0%, causing the membranes to be less permeable. It was found that the diameter of the largest pores in hydrogel membranes was in the range 7.2-8.0 nm. Based on the relationship between solute size and its molecular weight, the capsules had an approximate exclusion limit of 21-25 kD for dextran and 78-103 kD for protein, which is sufficient to block the antibodies penetrating through the membrane.     

Poly(methyl methacrylate)-grafted chitosan microspheres for controlled release of ampicillin

Microspheres of 50-500 microm diameter were prepared from a blend of chitosan and chitosan-g-PMMA. Environmental scanning electron microscopic and SEM studies revealed that the microspheres are porous and the pores extend toward the inner core of the microspheres. The microspheres were also found to be hemocompatible and cytocompatible. A model drug ampicillin was used to evaluate the drug loading capacity and the controlled release properties of the microspheres. The system maintained a sustained release of ampicillin for a period of more than 8 days. The drug-loaded chitosan/chitosan-g-PMMA microspheres exhibited higher antibacterial activity for both the gram positive (ATCC 25923 S. aureus) and gram negative (ATCC 25922 E. coli) bacteria than the drug-loaded virgin chitosan microspheres. The percentage release and bioactivity of ampicillin was found to be higher for the chitosan/chitosan-g-PMMA microspheres than the virgin chitosan microspheres. Potential applications such as oral drug delivery, wound dressings, tissue engineering, and so forth, are envisaged from these microspheres.     

Characterisation and epitope analysis of monoclonal antibodies to virions of clover yellow vein and Johnsongrass mosaic potyviruses

Summary Mouse monoclonal antibodies (MAbs) against the Australian B strain of clover yellow vein (C1YVV-B) and the JG strain of Johnsongrass mosaic (JGMV) potyviruses were produced, characterised and the epitopes with which they reacted were deduced. Using intact particles of C1YVV a total of ten MAbs were obtained which reacted strongly with C1YVV-B in an enzyme-linked immunosorbent assay and Western blots. Four of these MAbs (1, 2, 4, and 13) were found to be ClYVV-specific, as they reacted with all five C1YVV strains from Australia and the U.S.A. but not with 11 strains of bean yellow mosaic (BYMV), pea mosaic (PMV), and white lupin mosaic (WLMV) viruses which, together with C1YVV, form the BYMV subgroup of potyviruses. These MAbs failed to react with eight other potyvirus species, including six which infect legumes like the viruses in the BYMV subgroup. The C1YVV MAb 10 was found to be BYMV subgroup-specific. It reacted strongly with 15 of the 16 strains of viruses in the subgroup and gave no reaction with eight other potyviruses. The other five C1YVV MAbs reacted with varying degrees of specificity with the BYMV subgroup viruses and also with other potyviruses. Eight of the C1YVV MAbs (1, 2, 4, 5, 13, 17, 21, and 22) reacted with the intact coat proteins only and not with the truncated (minus amino terminus) coat protein of C1YVV suggesting that the epitopes for these MAbs are located in the surface-exposed, amino-terminal region of the C1YVV coat protein. Comparison of published coat protein sequences of BYMV and C1YVV isolates indicated that the epitopes for the four ClYVV-specific MAbs may be in the amino-terminal region spanning amino acid residues 18 to 30, whereas those for the other four MAbs may be located in the first 17 amino-terminal amino acid residue region. The epitopes that reacted with BYMV subgroup-specific MAb 10 and MAb 30 which reacted with 20 of the 24 potyvirus isolates, are probably located in the core region of C1YVV coat protein as these MAbs reacted with the intact as well as truncated coat protein of C1YVV. Analysis, in Western blot immunoassay, of 17 MAbs raised against virions of JGMV revealed that only two MAbs (1–25 and 4–30) were JGMV-specific, whereas others displayed varying degrees of specificity to different potyviruses. When these MAbs were screened against the intact and truncated (minus 67 amino-terminal amino acid residues) coat proteins of JGMV, the two JGMV-specific MAbs reacted only with the intact coat protein, whereas the other MAbs reacted with the intact as well as with truncated coat proteins, in Western blots. These results suggest that the epitopes for the two JGMV-specific MAbs are located in the surface-exposed amino-terminal 67 amino acid residue region and those for the cross-reactive MAbs are contained in the conserved core region of the JGMV coat protein. Screening of potyvirus MAbs against intact and truncated coat proteins thus appears to be a simple procedure to select virus-specific MAbs to potyviruses.     

Selection of polyclonal antibodies to the N terminus of bean yellow mosaic potyvirus coat protein by induction of tolerance with monoclonal antibody

Polyclonal antisera to potyviruses contain virus-specific as well as cross-reacting antibodies. The virus-specific antibodies are directed to the surface-located, N-terminal region of the coat protein, whereas cross-reacting antibodies are produced against multiple epitopes within the core region of the coat protein (minus N and C termini), which displays extensive sequence homology among distinct potyviruses. In the present study, immunological tolerance was induced in mice against the cross-reactive central core region of bean yellow mosaic virus (BYMV) using a rat monoclonal antibody (mAb) to the L3T4 molecule (the mouse equivalent of CD4). Generation of specific antisera reactive to the N terminus of BYMV was attained in tolerized mice by secondary immunization with whole viral coat protein from BYMV. This approach appears to be ideally suited to potyviruses where a two-third of the coat protein molecule contains immunogenic epitopes which can result in cross-reacting antibodies.     

Restoration of exocytosis occurs after inactivation of intracellular tetanus toxin.

Tetanus toxin blocks carbachol-stimulated release of noradrenaline from bovine adrenal chromaffin cells in culture, provided it can gain access to the cells. This can be achieved by electropermeabilization of the plasma membrane or by enriching the membrane with exogenous gangliosides which serve as carriers of the toxin. The inhibition of noradrenaline release persists for at least 6 days, even in the presence of specific anti-tetanus toxin antibodies in the culture medium. However, the block is preventable, for the most part, when antibodies enter chromaffin cells during electropermeabilization, before the uptake of the toxin is facilitated by inserting exogenous gangliosides into the plasma membrane 2 days later. This indicates that the antibodies pass into the cells through the physically induced pores and that these intracellular antibodies neutralize incoming tetanus toxin. If, on the other hand, exocytosis has been inhibited by tetanus toxin, it will recover within 3 days, provided specific anti-tetanus toxin antibodies are introduced into the cells by electropermeabilization. The recovery is not linked to a specific route of entry of the toxin. It is concluded that the restoration of noradrenaline release requires not only the intracellular neutralization of tetanus toxin but also the reconstitution of the as yet unknown target molecule of the toxin.     

Functional studies on purified eosinophils and neutrophils from patients with Schistosoma mansoni infections.

Unpurified peripheral blood leucocytes or purified eosinophils and neutrophils from patients with schistosomiasis and from normal individuals were compared for their ability to interact with antibody coated schistosomula of Schistosoma mansoni. There was no difference in the ability of buffy coat cells or neutrophils from patients and from normal individuals to mediate antibody-dependent 51Cr release from labelled schistosomula. However, eosinophils from patients were significantly better than those from normal individuals in causing antibody-dependent 51Cr release. This enhanced activity of eosinophils from patients with schistosomiasis was found to correlate with the intensity of their infection as judged by faecal egg counts. Eosinophils from patients also contained a higher proportion of cells with detectable Fc receptors than those from normal individuals. It is suggested that the difference in the behaviour of eosinophils from patients and from normals may reflect an 'activated' state of these cells in the infected individuals.     

Release characteristics and processing-structure-performance relationship of electro-spinning curcumin-loaded polyethersulfone based porous ultrafine fibers

Abstract

Polymeric porous ultrafine fibers with different structures as drug carrier could be facilely prepared. However, the drug release characteristics and relevant mechanism of different structural porous ultrafine fibers were not well studied. In the present work, different structural Poly-Ether-Sulfone (PES) based porous ultrafine fibers, namely PES, PES/Poly-Ethylene-Glycol (PEG) and PES/Water were prepared by electro-spinning. Curcumin was chosen as drug model loaded in these fibers. Investigation of curcumin release characteristics was carried out by the total immersion in buffer solution. The surface and inner structure of PES based ultrafine fibers were studied by scanning electron microscopy (SEM) in detail. It is found that there is significant difference in the accumulate release amount and release rate with similar structure. About 92.5% of curcumin released within 600?min for PES/PEG ultrafine fibers and only 58.9% of curcumin flowed out from PES with 1000?min. In order to discuss the fact of this phenomenon, the development structure of PES based porous ultrafine fibers was studied with curcumin release. The results indicated that the curcumin release was directly involved with the structure. For PES/PEG, curcumin around the surface layer released in advance. And then, some penetrable structure emerged with PEG dissolving in the buffer solution, which result in larger specific surface area and more embedded curcumin from the interior structure of the ultrafine fibers diffusing out. For the others, curcumin release only through its own pores of ultrafine fibers. Finally, the processing-structure-performance relationship of PES based porous ultrafine fibers were confirmed by the diversity of porosity and contact angle. The research results demonstrate that PES based porous ultrafine fibers have the potential to be used as drug carrier in the drug delivery according to the practical clinical requirements.     

Sequence diversity in the coat protein coding region of the genome RNA of <Emphasis Type="Italic">Johnsongrass mosaic virus</Emphasis> in Australia

Summary. Sequence diversity in the coat protein coding region of Australian strains of Johnsongrass mosaic virus (JGMV) was investigated. Field isolates were sampled during a seven year period from Johnsongrass, sorghum and corn across the northern grain growing region. The 23 isolates were found to have greater than 94% nucleotide and amino acid sequence identity. The Australian isolates and two strains from the U.S.A. had about 90% nucleotide sequence identity and were between 19 and 30% different in the N-terminus of the coat protein. Two amino acid residues were found in the core region of the coat protein in isolates obtained from sorghum having the Krish gene for JGMV resistance that differed from those found in isolates from other hosts which did not have this single dominant resistance gene. These amino acid changes may have been responsible for overcoming the resistance conferred by the Krish gene for JGMV resistance in sorghum. The identification of these variable regions was essential for the development of durable pathogen-derived resistance to JGMV in sorghum.